Protego Biopharma Raises $51 Million Series A Financing to Advance the Treatment of Protein Misfolding Diseases
November 17, 2021 09:02 ET
|
Protego Biopharma, Inc.
- Lightspeed Venture Partners and Vida Ventures join seed investor MPM Capital to lead Series A financing - - Protego’s proprietary technology platforms based on pioneering work from the Scripps...